Life
Briefing: Merck to Acquire Terns Pharmaceuticals for $6.7 Billion
Strategic angle: The acquisition aims to enhance Merck's portfolio with a promising leukemia treatment.
Editorial Staff about 1 month ago
#Leukemia Treatment
1 article tagged with "Leukemia Treatment"